-+ 0.00%
-+ 0.00%
-+ 0.00%

PROTAGONIST THERAPEUTICS, INC. : BMO RAISES TARGET PRICE TO $178 FROM $112

Reuters·08/17/2026 11:00:21

Please log in to view news